HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rajgopal Govindarajan Selected Research

Nucleoside Transport Proteins (Nucleoside Transporter)

6/2022Solute Carrier Nucleoside Transporters in Hematopoiesis and Hematological Drug Toxicities: A Perspective.
1/2021Facilitative lysosomal transport of bile acids alleviates ER stress in mouse hematopoietic precursors.
1/2019Adult stem cell deficits drive Slc29a3 disorders in mice.
4/2015Defective hCNT1 transport contributes to gemcitabine chemoresistance in ovarian cancer subtypes: overcoming transport defects using a nanoparticle approach.
3/2011CNT1 expression influences proliferation and chemosensitivity in drug-resistant pancreatic cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rajgopal Govindarajan Research Topics

Disease

13Neoplasms (Cancer)
05/2022 - 12/2002
9Pancreatic Neoplasms (Pancreatic Cancer)
05/2022 - 03/2011
3Inborn Genetic Diseases (Disease, Hereditary)
06/2022 - 01/2019
3Neoplasm Metastasis (Metastasis)
05/2022 - 11/2016
2Anemia
06/2022 - 01/2021
2Diabetes Mellitus
01/2018 - 09/2010
2Adenocarcinoma
11/2016 - 08/2005
2Infections
09/2016 - 10/2009
2Carcinoma (Carcinomatosis)
04/2015 - 08/2008
2Ovarian Neoplasms (Ovarian Cancer)
04/2015 - 01/2013
2Breast Neoplasms (Breast Cancer)
09/2013 - 08/2005
2Histiocytosis
01/2012 - 09/2010
2Hypertrichosis
01/2012 - 09/2010
1Drug-Related Side Effects and Adverse Reactions
06/2022
1Nephrotic Syndrome (Syndrome, Nephrotic)
04/2022
1Hypoalbuminemia
04/2022
1Nephrosis
04/2022
1Proteinuria
04/2022
1Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
01/2022
1Chronic Renal Insufficiency
01/2022
1Neuroinflammatory Diseases
11/2021
1Alzheimer Disease (Alzheimer's Disease)
11/2021
1Acute Kidney Injury (Acute Renal Failure)
01/2020
1Osteoporosis
01/2018
1Leukemia
11/2016
1Teratocarcinoma
04/2015
1Histiocytosis with joint contractures and sensorineural deafness
01/2012
1Contracture
01/2012

Drug/Important Bio-Agent (IBA)

9NucleosidesIBA
06/2022 - 04/2009
8GemcitabineFDA Link
05/2022 - 03/2011
5Nucleoside Transport Proteins (Nucleoside Transporter)IBA
06/2022 - 03/2011
5Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2010
5Pharmaceutical PreparationsIBA
04/2015 - 08/2005
3Cadherins (E-Cadherin)IBA
01/2021 - 12/2010
33-deazaneplanocinIBA
01/2017 - 01/2013
3MicroRNAs (MicroRNA)IBA
01/2017 - 01/2013
3Histones (Histone)IBA
11/2016 - 01/2013
3Ribavirin (Virazole)FDA LinkGeneric
09/2016 - 04/2009
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2021 - 08/2005
2Equilibrative Nucleoside Transporter 1IBA
01/2021 - 08/2008
2Oncogene Proteins (Oncogene Protein)IBA
09/2017 - 01/2013
2Capecitabine (Xeloda)FDA Link
01/2017 - 07/2012
2Insulin (Novolin)FDA Link
01/2012 - 09/2010
1lesinuradIBA
05/2022
1Glutathione (Reduced Glutathione)IBA
05/2022
1Pioglitazone (Actos)FDA Link
04/2022
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
04/2022
1CholesterolIBA
04/2022
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2022
1Mitogen-Activated Protein KinasesIBA
11/2021
1lissamine rhodamine B (sulforhodamine B)IBA
11/2021
1thiazolyl blueIBA
11/2021
1trans-sodium crocetinate (crocetin)IBA
11/2021
1Beclin-1IBA
11/2021
1Glycogen Synthase Kinase 3 betaIBA
11/2021
1Regulatory-Associated Protein of mTORIBA
11/2021
1Adenosine Triphosphate (ATP)IBA
11/2021
1Amyloid (Amyloid Fibrils)IBA
11/2021
1Carrier Proteins (Binding Protein)IBA
11/2021
1Cathepsin BIBA
11/2021
1Glial Fibrillary Acidic ProteinIBA
11/2021
1Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
11/2021
1Peptide Initiation Factors (Initiation Factor)IBA
11/2021
1Peptides (Polypeptides)IBA
11/2021
1Phosphotransferases (Kinase)IBA
11/2021
1Transcription Factors (Transcription Factor)IBA
11/2021
1N-Methylaspartate (NMDA)IBA
11/2021
1Amyloid beta-PeptidesIBA
11/2021
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
11/2021
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
11/2021
1Sirolimus (Rapamycin)FDA Link
11/2021
1Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA
11/2021
170-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
11/2021
1Calcium-Calmodulin-Dependent Protein Kinase KinaseIBA
11/2021
1AMP-Activated Protein KinasesIBA
11/2021
1Epithelial Cell Adhesion MoleculeIBA
01/2021
1Bile Acids and Salts (Bile Acids)IBA
01/2021
1ElectrolytesIBA
01/2020
1Protein Isoforms (Isoforms)IBA
09/2017
1Transforming Growth Factor-beta Type I ReceptorIBA
01/2017
1Transforming Growth Factor-beta Type II ReceptorIBA
01/2017
1HydrolasesIBA
11/2016
1Messenger RNA (mRNA)IBA
11/2016
1S-Adenosylmethionine (Ademetionine)IBA
11/2016
1Enhancer of Zeste Homolog 2 ProteinIBA
11/2016
1MethyltransferasesIBA
11/2016
1HomocysteineIBA
11/2016
1PlatinumIBA
04/2015
1Complementary DNA (cDNA)IBA
09/2013
1Thiamine (Aneurin)FDA Link
09/2013
1Thiamine PyrophosphateIBA
09/2013
1EnzymesIBA
09/2013
1DeoxyribonucleotidesIBA
01/2013
1RNA-Binding Proteins (RNA-Binding Protein)IBA
01/2013
1Small Interfering RNA (siRNA)IBA
01/2013
1GTP-Binding Proteins (G-Protein)IBA
01/2013
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2013

Therapy/Procedure

5Therapeutics
01/2021 - 01/2013
4Drug Therapy (Chemotherapy)
01/2021 - 08/2005
1Combination Drug Therapy (Combination Chemotherapy)
11/2016